Company profile: FineHeart
1.1 - Company Overview
Company description
- Provider of France-based innovative cardiovascular medical devices, including the FLOWMAKER®, a fully implantable, wirelessly powered mechanical circulatory support device that optimizes cardiac output while preserving heart contractility. Offers ICOMS FLOWMAKER® clinical trials to evaluate safety and performance in advanced heart failure, and partners with Lauak Group to manufacture pump parts, with final assembly in-house.
Products and services
- Manufacturing partnership with Lauak Group: FineHeart collaborates with Lauak Group to fabricate FLOWMAKER® pump parts, with final assembly performed in-house, ensuring component consistency and readiness for device integration
- ICOMS FLOWMAKER® clinical trials: FineHeart conducts the First in Human Study, BRIDGE Trial, CONFIRM Trial, and EXPAND Trial to evaluate safety and performance in patients with advanced heart failure
- FLOWMAKER®: FineHeart engineers a fully implantable, wirelessly powered mechanical circulatory support device designed to optimize cardiac output while preserving heart contractility in patients with advanced heart failure
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to FineHeart
Corvidia Therapeutics
HQ: United States
Website
- Description: Provider of clinical-stage research, development, and commercialization of transformative therapies for cardio-renal diseases, currently developing potential treatments for chronic kidney disease with atherosclerotic cardiovascular disease and inflammation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Corvidia Therapeutics company profile →
WR Medical
HQ: United States
Website
- Description: Provider of medical devices.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full WR Medical company profile →
AdjuCor
HQ: Germany
Website
- Description: Provider of reBEAT, a minimally invasive, epicardial, biventricular mechanical circulatory support device that assists one or both ventricles of the failing heart without blood contact; responsible for development, production, marketing, and selling of this technology for heart failure patients.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full AdjuCor company profile →
TYRX
HQ: United States
Website
- Description: Provider of medical-pharmaceutical combination devices and resorbable polymeric biomaterials delivering site-specific therapy for multiple surgical markets. Offers PIVIT CRM, a mesh-based pouch with antibacterial agents to protect against microbial colonization of the generator or defibrillator during and immediately after surgical implant; also provides AIGISRx.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full TYRX company profile →
Direct Flow Medical
HQ: United States
Website
- Description: Provider of medical implants used in the treatment of aortic and heart valve diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Direct Flow Medical company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for FineHeart
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to FineHeart
2.2 - Growth funds investing in similar companies to FineHeart
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for FineHeart
4.2 - Public trading comparable groups for FineHeart
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →